-
Notifications
You must be signed in to change notification settings - Fork 0
Ellinwood et al. integrated a Markov model of the IKur current derived from Zhou et al. (PLoS ONE 2012; e42295), modified to fit voltage-clamp data from human atrial myocytes, into the Morotti et al. human atrial model (J Mol Cell Cardiol. 2016 Jul; 96:63-71, available for download on this webpage). The IKur current model was extended to reprodu…
drgrandilab/Ellinwood-et-al-2017-Human-Atrial-Model-with-Updated-IKur
Folders and files
Name | Name | Last commit message | Last commit date | |
---|---|---|---|---|
Repository files navigation
Matlab code for Ellinwood et al. human atrial model with updated IKur formulation. Ellinwood et al. integrated a Markov model of the IKur current derived from Zhou et al. (PLoS ONE 2012; e42295), modified to fit voltage-clamp data from human atrial myocytes, into the Morotti et al. human atrial model (J Mol Cell Cardiol. 2016 Jul; 96:63-71, available for download on this webpage). The IKur current model was extended to reproduce dose-dependent drug binding to various conformational states of the channel with variable affinity and binding kinetics. _____________________________________________________________________________________________________ Contents: readme.txt this file Ellinwood_et_al_ham_ikur_drug_model_main.m loads initial conditions and runs the simulation Ellinwood_et_al_ham_ikur_drug_model.m excitation-contraction coupling model Ellinwood_et_al_ham_ikur_calcCurrents.m supporting function for simulation output analysis .mat files initial conditions (steady-state, drug-free) - yf_ham_ikur_df_1Hz nSR condition, 1-Hz pacing - yf_ham_ikur_df_1Hz nSR condition, 3-Hz pacing - yf_ham_ikur_df_1Hz_cAF cAF condition, 1-Hz pacing - yf_ham_ikur_df_3Hz_cAF cAF condition, 3-Hz pacing _____________________________________________________________________________________________________ References: Ellinwood N, Dobrev D, Morotti S, Grandi E. (2017). Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity. Chaos 27, 093918 (2017). doi: https://doi.org/10.1063/1.5000226 [See Erratum, Chaos 27, 109902 (2017). doi: https://doi.org/10.1063/1.5007051] Ellinwood N, Dobrev D, Morotti S, Grandi E. (2017). In silico assessment of efficacy and safety of IKur inhibitors in chronic atrial fibrillation: role of kinetics and state-dependence of drug binding Front. Pharmacol. 2017; 8: 799. doi: https://doi.org/10.3389/fphar.2017.00799 Morotti S, McCulloch AD, Bers DM, Edwards AG, Grandi E. (2015). Atrial-selective targeting of arrhythmogenic phase-3 earlyafterdepolarizations in human myocytes. J Mol Cell Cardiol. 2016 Jul;96:63-71. doi: https://doi.org/10.1016/j.yjmcc.2015.07.030 Grandi E, Pandit SV, Voigt N, Workman AJ, Dobrev D, Jalife J, Bers DM. (2011). Human Atrial Action Potential and Ca2+ Model: Sinus Rhythm and Chronic Atrial Fibrillation. Circ Res. 2011 Oct 14;109(9):1055-66. doi: https://doi.org/10.1161/CIRCRESAHA.111.253955 Please cite the above papers when using this model.
About
Ellinwood et al. integrated a Markov model of the IKur current derived from Zhou et al. (PLoS ONE 2012; e42295), modified to fit voltage-clamp data from human atrial myocytes, into the Morotti et al. human atrial model (J Mol Cell Cardiol. 2016 Jul; 96:63-71, available for download on this webpage). The IKur current model was extended to reprodu…
Resources
Stars
Watchers
Forks
Releases
No releases published
Packages 0
No packages published